Qube Research & Technologies (QRT)’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$15.1K	Buy	+12,692	New	+$15.1K	﹤0.01%	2489
2024 Q1	–	Sell	-260	Closed	-$1.28K	–	3886
2023 Q4	$1.28K	Buy	260 +122	+88%	+$600	﹤0.01%	3422
2023 Q3	$1.32K	Buy	+138	New	+$1.32K	﹤0.01%	3174